Form 4: Incyte Officer Plans Option Exercise, Share Sales
Insider Transaction Report
Incyte's Principal Accounting Officer, Tray Thomas, reported planned exercises of stock options and sales of common stock under a 10b5-1 plan.
Summary
- Tray Thomas, Principal Accounting Officer of Incyte Corp (INCY), filed a Form 4 detailing future transactions under a Rule 10b5-1(c) plan.
- On December 18, 2025, Thomas plans to sell 600 shares of common stock at a price of $98.25 per share.
- On December 19, 2025, Thomas plans to exercise Incentive Stock Options for 1,044 shares at an exercise price of $95.76 per share.
- Also on December 19, 2025, Thomas plans to exercise Non-Qualified Stock Options for 1,730 shares at an exercise price of $95.76 per share.
- Concurrently on December 19, 2025, Thomas plans to sell 2,774 shares of common stock at a price of $100 per share.
- Following these planned transactions, Thomas's direct beneficial ownership of Incyte common stock will be 22,973 shares.
- This beneficial ownership figure includes 15,166 shares of common stock issuable from previously reported restricted stock units that have not yet vested.
- The stock options exercised were fully vested and exercisable as of March 11, 2022, and are set to expire on January 6, 2026.
Sentiment
Score: 5
Explanation: The filing reports routine, pre-planned insider transactions under a 10b5-1 plan, which are generally neutral in sentiment as they are not indicative of new information or a change in management's outlook on the company's prospects.
Positives
- The officer is exercising stock options at $95.76 and selling shares at higher prices ($98.25 and $100), indicating a profitable transaction for the individual.
- The transactions are pre-planned under a Rule 10b5-1(c) plan, suggesting they are not based on new, non-public information and are part of a structured financial strategy.
Negatives
- The planned sales will result in a net reduction of the officer's direct common stock holdings, although this is common for liquidity or tax planning following option exercises.
Future Outlook
The filing details pre-planned insider transactions scheduled for December 2025, indicating a structured approach to managing equity compensation and personal holdings rather than a reaction to immediate market conditions.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity, specifically pre-planned transactions under a 10b5-1 plan. Such filings are common across all industries for publicly traded companies as executives manage their equity compensation and personal investment portfolios.
Stakeholder Impact
- Shareholders: Provides transparency into an officer's planned equity transactions, which are routine and pre-scheduled, thus unlikely to signal new information.
Key Dates
| Date | Description |
|---|---|
| 03/11/2022 | Date when the Incentive Stock Options and Non-Qualified Stock Options became fully vested and exercisable. |
| 12/18/2025 | Planned transaction date for the sale of 600 shares of common stock. |
| 12/19/2025 | Planned transaction date for the exercise of 1,044 Incentive Stock Options and 1,730 Non-Qualified Stock Options, and the sale of 2,774 shares of common stock. |
| 12/22/2025 | Date the Form 4 filing was signed. |
| 01/06/2026 | Expiration date of the Incentive Stock Options and Non-Qualified Stock Options. |
Keywords
Incyte, INCY, Form 4, Insider Transaction, Stock Options, Share Sale, Beneficial Ownership, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.